Tatva Chintan Pharma Chem Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹85.42Cr |
Net Profits | ₹3.46Cr |
Net Profit Margins | 4.05% |
Highlights
Revenue:
Tatva Chintan Pharma Chem Ltd’s revenue fell -29.8% since last year same period to ₹85.42Cr in the Q3 2023-2024. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated -12.33% fall in its revenue since last 3-months.
Net Profits:
Tatva Chintan Pharma Chem Ltd’s net profit fell -70.22% since last year same period to ₹3.46Cr in the Q3 2023-2024. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated -55.53% fall in its net profits since last 3-months.
Net Profit Margins:
Tatva Chintan Pharma Chem Ltd’s net profit margin fell -57.58% since last year same period to 4.05% in the Q3 2023-2024. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated -49.27% fall in its net profit margins since last 3-months.
